On 10 Aug 2003 10:34:31 GMT, Brian Sandle
posted:

Moosh:] wrote:
On 3 Aug 2003 10:18:13 GMT, Brian Sandle
posted:

In 1929 cotton breeds were always thought to have limited life.

They still do, don't they?

Maybe that is why Gordon got into a technical huff over the meaning of
variety vs breed when I tabulated all those names -- to avoid the subject.

Our scientists have not been able to make many important parts for the
human body as an alternative to getting them from human donors. I don't
see how they can keep up with the constant change of life's genome, the
fluidity and ecology needed for health, even in cotton.

They are making great strides in human tissue growth, I believe.

It is shown by the biotech slump.

That shows the fickleness of the stock market gamblers.

Biotech century ending?

This miniseries charts the further collapse of the biotech empire,
particular in the supposedly `highly lucrative' biomedical sector
since the latter part of 2000. It is now desperately grasping for
support from the taxpayer by hyping genetics and bio-defence. Don't be
fooled.

[This is from

Linkname: Genetics & Bio-Defence Research Rescue Biotech Slump
URL: http://www.i-sis.org.uk/GBBBS.php

see page for these leads:

1. Genetics & Bio-Defence Research Rescue Biotech Slump
2. Gene Therapy Risks Exposed
3. Death Sentence on Cloning
4. Pig Organ Transplants Dangerous & Costly
5. Animal Pharm Folds]
__________________________________________________ _______________

Genetics & Bio-Defence Research Rescue Biotech Slump

Bad science and dangerous medicine are bringing down the biotech
empire, but our governments are throwing more good money after it. Dr.
Mae-Wan Ho reports.

The complete document with references, is available in the ISIS
members site. Full details here

The biotech slump is nowhere more visible than in Washington DC, where
the industry congregated at the end of June to get the federal
government to fill the funding void. The desperate Biotechnology
Industry Organization (BIO) mounted an unusually extensive public
outreach campaign for its annual meeting, with a barrage of
advertising in newspapers and TV, and a two-day festival on the
National Mall.

Last year saw only 4 biotech companies go public, a 10-fold drop since
2000; in Europe, only 3 biotech companies went public last year.
Venture capital for new firms totaled $465 million, a drop of 70%
compared to the same period in 2002. So, hope turns to the US
government.

[...]
The futility of identifying `predisposing genes' in the human genome
is becoming increasingly clear as genes and genomes are now known to
mutate, reshuffle and rearrange in response to environmental toxins
and hazards (see "Health & the fluid genome" miniseries). Gene
technology projects, from animal bio-pharming and cloning to gene
therapy and xenotransplantation are collapsing because they have
failed to deliver the goods and the inherent hazards involved have
become all too evident (see other articles in this series). It is time
our governments stop throwing good money after bad medicine and invest
in genuinely health-enhancing projects that improve the quality of our
food, our air, water and land.
[...]

RELEVANT LINKS
from the ISIS website
(see all articles on the SITE MAP)
The Need for Another Research Paradigm
MRC Acknowledges GM Food Risks
Why We Should Reject Biotech Patents from TRIPS
Bush U-Turn on Bioweapons & GM
Re- The proposed decision to add Chardon LL Aventis -T25 Maize to the
National List
The Principle of Substantial equivalence is Unscientific and Arbitary
MAFF Reveals New Scientific Findings Confirming Fears Over Health
Hazards of GMOs
Biodefence in Tatters
Open Letter from World Scientists to All Governments


Sorry, I always distrust those with an axe to grind. The science comes
off second best, IME.